AstraZeneca (AZN) RNS Announcements

Add to Alert list
Date Time Source Announcement
06 Feb 2001 05:00 PM
RNS
Director Shareholding
01 Feb 2001 12:52 PM
RNS
Re Agreement
19 Jan 2001 01:30 PM
RNS
Disposal
09 Jan 2001 09:13 AM
RNS
Stmnt re Genpharm Inc
04 Jan 2001 10:00 AM
RNS
Stmnt re MRP Approval
22 Dec 2000 10:30 AM
RNS
Director Shareholding
19 Dec 2000 02:00 PM
RNS
Court Ruling
12 Dec 2000 09:45 AM
RNS
Result of Meeting - Part 2
12 Dec 2000 09:45 AM
RNS
Result of Meeting - Part 1
11 Dec 2000 09:15 AM
RNS
Notice of Meeting
17 Nov 2000 04:38 PM
RNS
Director Shareholding
17 Nov 2000 04:38 PM
RNS
Director Shareholding
17 Nov 2000 01:15 PM
RNS
Court Ruling
15 Nov 2000 04:00 PM
RNS
Director Shareholding
13 Nov 2000 11:02 AM
RNS
Re Directorate
13 Nov 2000 08:10 AM
RNS
Stmnt re Syngenta AG
13 Nov 2000 07:00 AM
RNS
Fthr reSyngentaGlobal Sec Off
02 Nov 2000 10:00 AM
RNS
Stmnt re FTC Approval
02 Nov 2000 07:30 AM
RNS
Syngenta Suppl. Prospectus
30 Oct 2000 12:00 PM
RNS
Stmnt re Divestment
30 Oct 2000 07:30 AM
RNS
Syngenta Global Secondary Off
26 Oct 2000 02:00 PM
RNS
Re Alliance
25 Oct 2000 07:00 AM
RNS
3rd Qrt & 9 Mths Results-Pt.2
25 Oct 2000 07:00 AM
RNS
3rd Qrt & 9 Mths Results-Pt.1
17 Oct 2000 12:12 PM
RNS
Corporate Action
11 Oct 2000 12:28 PM
RNS
Result of EGM
09 Oct 2000 09:16 AM
RNS
Patent Dispute
21 Sep 2000 04:00 PM
RNS
Director Shareholding
18 Sep 2000 07:13 AM
RNS
Notice of EGM, etc.
08 Sep 2000 03:17 PM
RNS
Mylan Lab./Mylan Pharms.
04 Sep 2000 09:30 AM
RNS
Regulatory Approval
29 Aug 2000 10:01 AM
RNS
Statement re Asthma Treatment
25 Aug 2000 02:16 PM
RNS
Directors' Notification of Dealing in Shares
01 Aug 2000 08:09 AM
RNS
Dividend Notification
01 Aug 2000 07:13 AM
RNS
2nd Qtr & Interim Rslts-Pt3
01 Aug 2000 07:07 AM
RNS
2nd Qtr & Interim Rslts-Pt2
01 Aug 2000 07:05 AM
RNS
Nexium Launch Date, etc.
01 Aug 2000 07:05 AM
RNS
2nd Qtr & Interim Rslts-Pt1
26 Jul 2000 01:24 PM
RNS
Merger Update
12 Jul 2000 09:30 AM
RNS
Regulatory Approval
21 Jun 2000 08:40 AM
RNS
Lawsuit Against Lek Pharmaceutical & Chemical
19 Jun 2000 02:00 PM
RNS
Disposal
12 Jun 2000 07:00 AM
RNS
Purchase of Own Securities
08 Jun 2000 07:00 AM
RNS
Purchase of Own Securities
07 Jun 2000 07:00 AM
RNS
Purchase of Own Securities
06 Jun 2000 07:00 AM
RNS
Purchase of Own Securities
30 May 2000 12:08 PM
RNS
Result of AGM
25 May 2000 07:00 AM
RNS
Purchase of Own Securities
24 May 2000 07:00 AM
RNS
Purchase of Own Securities
19 May 2000 07:00 AM
RNS
Purchase of Own Securities
AstraZeneca PLC, known as AZN on the London Stock Exchange (LSE), is an Anglo-Swedish multinational pharmaceutical and biotechnology company. Founded on April 6, 1999, AstraZeneca was formed through the merger of the Swedish Astra AB and the British Zeneca Group. The company's roots trace back to 1913, when Astra AB was established by a group of doctors and apothecaries in Södertälje, Sweden. Throughout the twentieth century, AstraZeneca grew into one of the largest pharmaceutical companies in the world. It has made numerous corporate acquisitions, including Cambridge Antibody Technology (in 2006), MedImmune (in 2007), Spirogen (in 2013) and Definiens (by MedImmune in 2014). Today, AstraZeneca operates in over 100 countries and employs around 83,000 people. As a member of the LSEG, AZN continues to shape the global healthcare landscape. The company is committed to defeating diseases that impact people's health.
UK 100